As most of the extracted data were obtained from patients with osteosarcoma, and in order to evaluate if the prognostic value of ezrin expression was limited to osteosarcoma, in the analysis of OS and EFS, a subgroup analysis according to tumor type (osteosarcoma vs. nonosteosarcoma) was performed. This evidence concerns the gene EZR and neoplasm.